GCP
AGRX

GSA Capital Partners’s Agile Therapeutics AGRX Stock Holding History

GSA Capital Partners’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-367
Closed -$358K – 1956
2021
Q4 		$358K Buy
367
+74
+25% +$104K 0.05% 817
2021
Q3 		$564K Buy
293
+107
+58% +$242K 0.06% 634
2021
Q2 		$495K Buy
186
+116
+166% +$382K 0.06% 635
2021
Q1 		$291K Buy
+70
New +$378K 0.05% 662
2020
Q4 		– Sell
-114
Closed -$693K – 1712
2020
Q3 		$693K Buy
+114
New +$653K 0.12% 237

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return